We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $7.93M | 0.03% |
194,091
+3,191
| +2% | +$128K |
|
502
Enbridge
ENB
$106B
| $7.93M | 0.03% |
218,704
+42,660
| +24% | +$1.54M |
|
503
Progress Software
PRGS
$1.79B
| $7.86M | 0.03% |
177,200
+6,300
| +4% | +$230K |
|
504
Chubb
CB
$132B
| $7.84M | 0.03% |
55,951
-986
| -2% | -$131K |
|
|
DGL
505
DELISTED
Invesco DB Gold Fund
DGL
| $7.83M | 0.03% |
197,205
+770
| +0.4% | +$30.9K |
|
506
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
| $7.81M | 0.03% |
54,700
| – | – |
|
507
TransUnion
TRU
$14.8B
| $7.74M | 0.03% |
115,800
-11,754
| -9% | -$728K |
|
508
Vishay Intertechnology
VSH
$4.82B
| $7.71M | 0.03% |
417,600
+360,740
| +634% | +$7.21M |
|
|
FPRX
509
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $7.7M | 0.03% |
574,920
+208,543
| +57% | +$2.38M |
|
|
BFS
510
Saul Centers
BFS
$759M
| $7.68M | 0.03% |
149,453
-95,233
| -39% | -$5.05M |
|
511
Cracker Barrel
CBRL
$1.01B
| $7.6M | 0.03% |
47,000
+38,600
| +460% | +$6.35M |
|
512
Greif
GEF
$4.63B
| $7.5M | 0.03% |
181,700
+7,300
| +4% | +$292K |
|
|
AIV
513
Aimco
AIV
$333M
| $7.49M | 0.03% |
+1,117,658
| New | +$7.21M |
|
|
WCC
514
WESCO International
WCC
$16.3B
| $7.48M | 0.03% |
141,100
+47,100
| +50% | +$2.49M |
|
515
Terex
TEX
$6.67B
| $7.46M | 0.03% |
232,100
+118,500
| +104% | +$3.76M |
|
516
Marathon Petroleum
MPC
$115B
| $7.36M | 0.03% |
123,027
-528
| -0.4% | -$33.2K |
|
517
iShares China Large-Cap ETF
FXI
$4.1B
| $7.31M | 0.03% |
165,115
| – | – |
|
|
LM
518
DELISTED
Legg Mason, Inc.
LM
| $7.27M | 0.03% |
+265,600
| New | +$7.62M |
|
|
MOMO
519
Hello Group
MOMO
$714M
| $7.26M | 0.03% |
189,816
+9,223
| +5% | +$295K |
|
520
Magna International
MGA
$17B
| $7.25M | 0.03% |
148,891
-42,228
| -22% | -$2.13M |
|
|
SIVB
521
DELISTED
SVB Financial Group
SIVB
| $7.22M | 0.03% |
32,468
-3,850
| -11% | -$896K |
|
522
TransDigm Group
TDG
$60B
| $7.22M | 0.03% |
15,895
+1,794
| +13% | +$728K |
|
|
SAGE
523
DELISTED
Sage Therapeutics
SAGE
| $7.2M | 0.03% |
45,270
| – | – |
|
524
Sabra Healthcare REIT
SBRA
$5.18B
| $7.18M | 0.03% |
368,946
-54,900
| -13% | -$1.04M |
|
|
525
Humana
HUM
$47.6B
| $7.13M | 0.03% |
26,817
-250,033
| -90% | -$72.1M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.